OWP Pharmaceuticals
Naperville, US · Illinois corporation
OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.
Founders & leadership
SB
STEVE BOURNEExecutive
SB
SCOTT BOYERNamed on SEC filing
Board
CG
CAROL GAVINBoard director
KF
KURT FLORIANBoard director
PR
PAUL REGANBoard director
TH
TROY HAMMONDBoard director
BD
BRUCE DUNCANBoard director
Reported raises · per SEC filings
Form D private placements$5.1M disclosed across 2 rounds · 2024–2025
▶$2.4MraisedSep 2025 · 19 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedSep 2025 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- TROY HAMMONDDirector
- STEVE BOURNEExecutive Officer
- MATT LITFINDirector
- KURT FLORIANDirector
- SCOTT BOYERExecutive Officer, Director
- BRUCE DUNCANDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $25K
- First sale
- Jul 2025
- Incorporated
- Corporation, Illinois
- Federal exemptions
- 06b
▶$2.7MraisedSep 2024 · 11 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedSep 2024 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- STEVE BOURNEExecutive Officer
- CAROL GAVINDirector
- SCOTT BOYERExecutive Officer, Director
- KURT FLORIANDirector
- PAUL REGANDirector
- TROY HAMMONDDirector
- BRUCE DUNCANDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Minimum investment
- $25K
- First sale
- Jun 2024
- Incorporated
- Corporation, Illinois
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapWalgreens6 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Bionpharma5 shared keywords
Companies competing with OWP Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does OWP Pharmaceuticals do?
- OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.
- How much funding has OWP Pharmaceuticals raised?
- OWP Pharmaceuticals has disclosed $5.1M raised across 2 rounds.
- Where is OWP Pharmaceuticals headquartered?
- OWP Pharmaceuticals is headquartered in Naperville, US.